000			04003nam a22004455i 4500
001			978-1-59259-970-7
003			DE-He213
005			20161121230702.0
007			cr nn 008mamaa
008			100301s2006 xxu| s |||| 0|eng d
020			_a9781592599707 _9978-1-59259-970-7
024	7		_a10.1007/978-1-59259-970-7 _2doi
050		4	_aQR180-189.5
072		7	_aMJCM _2bicssc
072		7	_aMED044000 _2bisacsh
082	0	4	_a616.079 _223
245	1	0	_aVaccine Adjuvants _h[electronic resource] : _bImmunological and Clinical Principles / _cedited by Charles J. Hackett, Donald A. Harn.
264		1	_aTotowa, NJ : _bHumana Press, _c2006.
300			_bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aInfectious Disease
505	0		_aMicrobial Pathogenesis and the Discovery of Toll-Like Receptor Function -- Dendritic Cells -- Achieving Transcriptional Specificity in NF-?B-Dependent Inflammatory Gene Expression -- Adjuvants and the Initiation of T-Cell Responses -- Mechanism for Recognition of CpG DNA -- CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines -- Modified Bacterial Toxins -- Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites -- The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens -- Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide -- Effects of QS-21 on Innate and Adaptive Immune Responses -- Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators -- Microparticles and DNA Vaccines.
520			_aRecent major advances in our understanding of basic immunology have led to the development of powerful new adjuvants-substances that can stimulate the innate immune system and significantly improve the effectiveness of antigen-based vaccines. In Vaccine Adjuvants: Immunological and Clinical Principles, highly respected clinical immunologists and vaccine researchers detail the major research areas in this new era of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses. Among the highlights are an explanation of innate immune signaling-including Toll-like receptors-in vaccination, and a preview of emerging technologies in adjuvant research, such as microparticles and novel lipid and carbohydrate adjuvants. Authoritative and eminently practical, Vaccine Adjuvants: Immunological and Clinical Principles moves from the basic principles of the innate immune system, through the characteristics of specific adjuvants, to detailed methods for developing the safer and more effective adjuvants that will trigger these powerful immune responses, and finally to the combinations of immune responses needed for successful vaccination.
650		0	_aMedicine.
650		0	_aImmunology.
650	1	4	_aBiomedicine.
650	2	4	_aImmunology.
700	1		_aHackett, Charles J. _eeditor.
700	1		_aHarn, Donald A. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9780896038929
830		0	_aInfectious Disease
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-59259-970-7
912			_aZDB-2-SBL
950			_aBiomedical and Life Sciences (Springer-11642)
999			_c502442 _d502442